Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells

Journal of Cellular Physiology

Volumn 213, Issue 3, 2007, Pages 699-709

  Pandolfi, Assunta ^a   Di Pietro, Natalia ^a   Sirolli, Vittorio ^a   Giardinelli, Annalisa ^a   Di Silvestre, Sara ^a   Amoroso, Luigi ^a   Di Tomo, Pamela ^a   Capani, Fabio ^a,b   Consoli, Agostino ^a   Bonomini, Mario ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Leonardo da Vinci Telematic University   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLSERINE; PROTEIN KINASE B; THROMBOSPONDIN 1; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN RECEPTOR;

ADULT; AGED; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ERYTHROCYTE ADHESIVENESS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; KIDNEY FAILURE; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN; UREMIA; VASCULAR DISEASE; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL ADHESION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RNA, MESSENGER; TIME FACTORS; U937 CELLS; UMBILICAL VEINS; UREMIA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 35848958833     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21138     Document Type: Article

References (43)

1. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. 2005. Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871.
2. Bhattacharya S, Patel R, Sen N, Quadri S, Parthasarathi K, Bhattacharya J. 2001. Dual signaling by the αvβ3-integrin activates cytosolic PLA2 in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 280:L1049-L1056.
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. 1999. Impact of aortic non survival in end-stage renal disease. Circulation 99:2434-2439.
4. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A. 1998. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399-407.
5. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A. 1999. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10:1982-1990.
6. Bonomini M, Sirolli V, Gizzi F, Di Stante S, Grilli A, Felaco M. 2002. Enhanced adherence of human uremic erythrocytes to vascular endothelium: Role of phosphatidylserine exposure. Kidney Int 62:1358-1363.
7. Bonomini M, Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Consoli A, Amoroso L, Gizzi F, De Lutiis MA, Felaco M. 2005. Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression. Kidney Int 67:1899-1906.
8. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB. 2004. Increasing expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 15:1495-1530.
9. Buzello M, Tornig J, Faulhaber J, Ehmeke H, Ritz E, Amann K. 2003. The apolipoprotein e-knockout mouse: A model documenting accelerated atherosclerosis in uremia. J Am Soc Nephrol 14:311-316.
10. Collins T, Cybulsky MI. 2001. NF-kB: Pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255-264.
11. Conforti G, Dominguez-Jimenez C, Zanetti A, Gimbrone MAJ, Cremona O, Marchisio PC, Dejana E. 1992. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 80:437-446.
12. De Caterina R, Libby P, Peng HB, Thaqnnickal VJ, Rajavashisth TB, Gimbrone MA, Jr., Shin WS. Liao JK. 1995. Nitric oxide decreases cytokine induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68.
13. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, Consoli A. 2004. G972R variant impairs insulin regulation of eNOS in cultured human endothelial cells. Circulation 109:399-405.
14. Fleming I, Busse R. 2003. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 284:R1-R12.
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
16. Hebbel RP, Boogaerts MAB, Eaton JW, Steinberg MH. 1980. Erythrocyte adherence to endothelium in sickle-cell anemia. N Engl J Med 302:992.
17. Joannides R, Bakkali EH, Le Roy F, Rivoult O, Godin M, Moore N, Fillastre JP, Thuillez C. 1997. Altered flow-dependent vasodilatation of conduit arteries in mainteinance haemodialysis. Nephrol Dial Transplant 12:2623-2628.
18. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. 2001. Vascular endothelial growth factor expression intercellular adhesion molecule 1 (ICAM-I), vascular adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kB anctivation in endothelial cells. J Biol Chem 276:7614-7620.
19. Kofler S, Nickel T, Weis M. 2005. Role of cytokines in cardiovascular diseases: A focus on endothelial responses to inflammation. Clin Sci 108:205-213.
20. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townsend JN, Baigent C. 2004. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43:244-253.
21. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. 2002. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for diagnostics. Am J Kidney Dis 40:472-479.
22. Lien SC, Usami S, Chien S, Chiu JJ. 2006. Phosphatydilinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal 18:1270-1278.
23. Lindner A, Charra B, Sherrard DJ, Scribner BH. 1975. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701.
24. Locatelli F, Del Vecchio L, Manzoni C. 1998. Morbidity and mortality on maintenance haemodialysis. Contrib Nephrol 124:166-189.
25. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. 2004. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a proatherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47:532-536.
26. Manodori AB. 2001. Sickle erythrocytes adhere to fibronectin- thrombospondin-integrin complexes exposed by thrombin-induced endothelial cell contraction. Microvasc Res 61:263-274.
27. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. 2000. Adherence of phosphatidyserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 95:1293-1300.
28. Mincione G, Esposito DL, Di Marcantonio MC, Piccirelli A, Cama A, Colletta G. 2003. TGF-beta-1 modulation of IGF-I signaling pathway in rat thyroid epithelial cells. Exp Cell Res 287:411-423.
29. Morris ST, Jardine AG. 2000. The vascular endothelium in chronic renal failure. J Nephrol 13:96-105.
30. Mukai Y, Rikitake Y, Shiojima I, Wolfrum S, Satoh M, Takeshita K, Hiroi Y, Salomone S, Kim HH, Benjamin LE, Walsh K, Liao JK. 2006. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest 116:334-343.
31. Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri AM, Koukoudis P, Memmos D. 2002. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 17:435-441.
32. Ritz E, McClellan WM. 2004. Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences. J Am Soc Nephrol 15:513-516.
33. Ross R. 1999. Atherosclerosis - An inflammatory disease. N Engl J Med 15:115-126.
34. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. 1979. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611.
35. Sarnak MJ, Levely AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCoullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. 2003. Kidney disease as a risk factor for the development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular, and Epidemiology and Prevention. Circulation 108:2154-2169.
36. Schmidt RJ, Baylis C. 2000. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261-1266.
37. Seliger SL, Gillen DL, Tircshwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO. 2003. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14:2623-2631.
38. Serradell M, Diaz-Ricart M, Cases A, Zurbano MJ, Lopez-Pedret J, Arranz O, Ordinas A, Escolar G. 2002. Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica 87:1053-1061.
39. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. 2003. Elevation of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92.
40. Singh B, Fu C, Bhattacharya J. 2000. Vascular expression of the αvβ3-integrin in lung and other organs. Am J Physiol Lung Cell Mol Physiol 278:L217-L226.
41. Styles L, de Jong K, Vichinsky E, Iubin L, Adams R, Kuypers FA. 1997. Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening. Blood 90:604a.
42. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kibert BA. 2001. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37:484-489.
43. Voraberger G, Schafer R, Stratowa C. 1991. Cloning of the human gene for intercellular adhesion molecule I and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol 147:2777-2786.